NASDAQ: LPCN
Lipocine Inc Stock Ownership - Who owns Lipocine?

Insider buying vs selling

Have Lipocine Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John W. HiguchiDirector2026-09-3015,970$2.23
$35.61kBuy
John W. HiguchiDirector2026-09-299,037$2.15
$19.43kBuy
John W. HiguchiDirector2026-09-2812,561$2.16
$27.13kBuy
John W. HiguchiDirector2026-04-0740,000$2.03
$81.20kBuy
John W. HiguchiDirector2026-04-06123,000$2.05
$252.15kBuy
Mahesh V. PatelChief Executive Officer2026-04-0625,000$2.03
$50.75kBuy
Mahesh V. PatelChief Executive Officer2026-04-0225,000$2.02
$50.50kBuy

1 of 1

LPCN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LPCN insiders and whales buy or sell their stock.

LPCN Shareholders

What type of owners hold Lipocine Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Israel Menahem Vizel36.39%3,000,000$4.38MInsider
Visium Balanced Master Fund Ltd14.63%1,206,000$1.76MInsider
William I. Higuchi10.82%891,876$1.30MInsider
Elan Corp PLC9.71%800,394$1.17MInsider
Ucb Manufacturing Ireland Ltd7.04%580,402$847.39kInsider
Mahesh V. Patel4.21%347,199$506.91kInsider
John W. Higuchi3.64%299,843$437.77kInsider
Morgan R. Brown2.36%194,504$283.98kInsider
Gordhan Patel0.90%74,583$108.89kInsider
Srinivasan Venkateshwaran0.27%22,337$32.61kInsider

1 of 3

LPCN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LPCN0.04%90.96%Net BuyingNet Buying
CLRB0.03%35.70%Net Buying
KAPA0.00%32.08%
HIND0.00%100.00%
TVRD0.01%99.99%

Lipocine Stock Ownership FAQ

Who owns Lipocine?

Lipocine (NASDAQ: LPCN) is owned by 0.04% institutional shareholders, 90.96% Lipocine insiders, and 9.00% retail investors. Israel Menahem Vizel is the largest individual Lipocine shareholder, owning 3.00M shares representing 36.39% of the company. Israel Menahem Vizel's Lipocine shares are currently valued at $4.32M.

If you're new to stock investing, here's how to buy Lipocine stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.